Powder: -20°C for 3 years | In solvent: -80°C for 1 year
GLX351322 is NADPH Oxidase 4 Inhibitor with IC50 of 5 μM.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
2 mg | 在庫あり | ¥ 10,000 | |||
5 mg | 在庫あり | ¥ 16,000 | |||
10 mg | 在庫あり | ¥ 26,000 | |||
25 mg | 在庫あり | ¥ 58,500 | |||
50 mg | 在庫あり | ¥ 100,000 | |||
100 mg | 在庫あり | ¥ 148,500 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 30,500 |
説明 | GLX351322 is NADPH Oxidase 4 Inhibitor with IC50 of 5 μM. |
ターゲット&IC50 | NOX2:40 μM, NOX4:5 μ M |
In vitro | In long-term experiments (1-3 days), high-glucose-induced human islet cell reactive oxygen species (ROS) production and death were prevented by GLX351322. |
分子量 | 431.51 |
分子式 | C21H25N3O5S |
CAS No. | 835598-94-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 20 mg/mL (46.35 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
GLX351322 835598-94-2 Immunology/Inflammation Metabolism NADPH-oxidase NADPH GLX 351322 NADPH Oxidase GLX-351322 NOX Inhibitor inhibit inhibitor